AstraZeneca shares slide after BMS merger talks report
By The BriefBrief
AstraZeneca shares fell after a Financial Times report said Bristol Myers discussed merger talks for months.
WHO:AstraZeneca; Bristol Myers Squibb; Financial Times
WHAT:A Financial Times report said Bristol Myers Squibb and AstraZeneca discussed potential merger talks for several months, prompting analysts to react and AstraZeneca shares to slide.
WHEN:Aug 3, 2026 at 5:50 AM ET
WHERE:Location not specified
WHY:The market reaction followed the Financial Times report about potential merger talks between the companies.
Reporting from 3 identified publishers across this event arc.